Thermo Fisher Scientific Inc. (TMO)

Over the past six months, Thermo Fisher Scientific's shares have outperformed the Zacks Medical - Instruments industry. Key events include strong Q4 2025 earnings, acquisitions such as a sterile fill-finish facility from Sanofi, and workforce reductions and facility closures to improve efficiency.

Demand for Thermo Fisher Scientific's products and services is driven by long-term trends such as biotechnology & genomics and precision medicine. While pandemic-related revenue is fading, the company is positioned to leverage market share gains. Slow organic revenue growth suggests a potential waning demand in its core business, but there is renewed demand for its services as pharmaceutical companies increase drug development and manufacturing in the U.S.

Thermo Fisher Scientific Inc. is a global leader providing life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and services, primarily in the healthcare sector. The company's offerings are categorized into Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services, serving various markets including pharmaceutical, biotechnology, academic, and government.

Thermo Fisher Scientific has a significant global presence with facilities across North America, Europe, and Asia-Pacific. The United States is a major hub with numerous manufacturing operations. The company also has a strong presence in European countries and has expanded operations in the Asia-Pacific region.

Thermo Fisher Scientific has been recognized for its excellence in contract manufacturing, receiving CDMO Leadership awards for several consecutive years. However, the company has faced past controversies regarding its equipment sales, leading to investigations and halting sales of certain products in specific regions.

The ownership structure of Thermo Fisher Scientific stock is a mix of institutional, retail, and individual investors. A significant percentage of the company's stock is owned by institutional investors, with the remainder held by insiders, public companies, and individual investors. Major institutional shareholders include State Street Corp., Manulife Financial Corp., and Swedbank AB.